CCL20 in Psoriasis: A Potential Biomarker of Disease Severity, Inflammation, and Impaired Vascular Health

Name: CCL20 in Psoriasis: A Potential Biomarker of Disease Severity, Inflammation, and Impaired Vascular Health
Creator: Youssef Elnabawi
Published: 2020-11-06T16:05:40.279Z
Keywords: Inflammation of Vascular Endothelium, Cardiovascular Disease Risk Factor, Risk Factor for Atherosclerosis, Disease Process of Psoriasis, Biomarker Discovery

Elnabawi, Youssef; Garshick, Michael; Tawil, Michael; Barrett, Tessa; Fisher, Edward; Lo Sicco, Kristen; Neimann, Andrea; Scher, Jose; Kreuger, James; Berger, Jeffrey

doi:10.17632/vnk9syjf8t.1

CCL20 in Psoriasis: A Potential Biomarker of Disease Severity, Inflammation, and Impaired Vascular Health

Published: 6 November 2020| Version 1 | DOI: 10.17632/vnk9syjf8t.1

Contributors:

Youssef Elnabawi, Michael Garshick, Michael Tawil, Tessa Barrett, Edward Fisher, Kristen Lo Sicco, Andrea Neimann, Jose Scher, James Kreuger, Jeffrey Berger

CCL20 in Psoriasis: A Potential Biomarker of Disease Severity, Inflammation, and Impaired Vascular Health

Description

Files

Institutions

Categories

Licence